Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
Sponsor: Relay Therapeutics, Inc.
Westwood, KS · Wichita, KS · +50 more sites
6 recruiting breast cancer studies with a site in Wichita, KS.
Sponsor: Relay Therapeutics, Inc.
Westwood, KS · Wichita, KS · +50 more sites
Sponsor: Stemline Therapeutics, Inc.
Wichita, KS · +175 more sites
Sponsor: Alliance for Clinical Trials in Oncology
Chanute, KS · Dodge City, KS · El Dorado, KS · +825 more sites
Sponsor: NRG Oncology
Kansas City, KS · Olathe, KS · Overland Park, KS · +809 more sites
Sponsor: Jonsson Comprehensive Cancer Center
Wichita, KS · +8 more sites
Sponsor: SWOG Cancer Research Network
Chanute, KS · Dodge City, KS · El Dorado, KS · +952 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.